The advent of microarray technology has led to a flurry of gene-expression profiling studies aimed at defining patients into more clinically-relevant groups at the same time as gaining new insights into cancer pathology. This is particularly evident for breast cancer research. What are the current limitations and future prospects for the translation of molecular signatures?
- Christos Sotiriou
- Martine J. Piccart